Module 05b. Cardiovascular PET Tracers - Part b-Myocardial Inflammation, Viability, and Amyloid Imaging (Slides)

Myocardial Inflammation, Viability, and Amyloid Imaging (Slides)

Pdf Summary

This document is a summary of the content in Part 3 of the Cardiovascular PET Tracers Module 5b. The module focuses on myocardial inflammation, viability, and amyloid imaging. <br /><br />It provides information on various topics, such as the protocols and principles for using FDG PET imaging for cardiac sarcoidosis, the interpretation and clinical application of FDG viability imaging, available tracers for cardiac amyloidosis, and the clinical application of FDG PET in diagnosing intracardiac, LVAD, and cardiac electronic device infections. <br /><br />The document also includes recommendations for when FDG cardiac PET should be considered, such as in cases of abnormal screening for cardiac sarcoidosis, unexplained new onset conduction disease in patients under 60, idiopathic sustained ventricular tachycardia, and follow-up of treatment response in patients with proven cardiac sarcoidosis. <br /><br />It mentions the importance of following specific dietary restrictions prior to the PET exam, including fasting and avoiding foods and drinks containing carbohydrates and sugars. <br /><br />The document references various studies and publications that provide additional information on the topics discussed, including the use of FDG PET for cardiac sarcoidosis, myocardial viability, amyloidosis, and infection. <br /><br />Overall, the document serves as a guide for understanding the use of cardiovascular PET tracers in imaging myocardial inflammation, viability, and amyloidosis.

Keywords

Cardiovascular PET Tracers

Myocardial Inflammation

Myocardial Viability

Amyloid Imaging

FDG PET Imaging

Cardiac Sarcoidosis

FDG Viability Imaging

Cardiac Amyloidosis

Intracardiac Infections

LVAD Infections